Safety and Efficacy of OPN Balloon in Patients With Calcified Coronary Artery Disease

被引:5
|
作者
Senguttuvan, Nagendra Boopathy [1 ,4 ]
Singh, Harsimran [1 ]
Kumar, Balakrishnan Vinod [1 ]
Kongara, Rahul Chowdary [1 ]
Abdulkader, Rizwan Suliankatchi [2 ]
Anandaram, Asuwin [3 ]
Krishnamurthy, Preetam [1 ]
Balasubramaniyan, Jayanthy Venkata [1 ]
Sadhanandham, Shanmugasundram [1 ]
Ramesh, Sankaran [1 ]
Manokar, Panchanatham [1 ]
Muralidharan, Thoddi Ramamurthy [1 ]
Murthy, Jayanthy S. N. [1 ]
Thanikachalam, Sadagopan [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Cardiol, 1 Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[2] Natl Inst Epidemiol, ICMR, Scientist D, Chennai, India
[3] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Clin Res, 1,Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[4] SRIHER, Dept Cardiol, Chennai, India
关键词
OPN balloon; Calcified lesions; Stent expansion; CAD; SIROLIMUS-ELUTING STENTS; LESIONS;
D O I
10.1016/j.carrev.2023.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with symptomatic calcified coronary lesions have poor outcomes. Such lesions require additional atherectomy devices for bed preparation. Aim: To assess the safety and efficacy of OPN balloon in patients with calcified coronary lesions.Methods: This is an investigator-initiated, prospective, observational study. The primary outcome of the study was a procedural success.Results: We studied 71 patients (133 lesions). Maximum lesions were located in LAD [46.6 %]. The OPN balloon was used for pre-dilatation alone in 28.6 % (Pre-stent OPN group), post-dilatation alone in 63.2 % of lesions (Post-stent OPN group), and in both situations in 8.3 % of lesions with procedural success in 98.5 % of patients. Further dilatation with different NC balloons was required in both groups (30 %). The median (IQR) OPN balloon diameter in the pre-and post-stent OPN group were 2.5 (2.5, 3.0) and 3.0 (3.0,3.0) mm (p = 0.001), respectively. The difference between the diameter of the stent and OPN balloon used in pre-stent OPN group was 0.5 (0.2, 0.5) mm while it was 0.0 (0.0,0.2) mm in the post-stent OPN group (p < 0.001). Eight complications and two deaths occured. Distal shaft rupture was also noticed. Conclusion: OPN balloon is safe, and effective in treating calcified coronary lesions. We propose to undersize the balloon by 0.5 mm for pre-dilatation followed by 0.25 mm larger NC balloon if needed. In the post-dilatation group, use a 1:1 size balloon in a non-tortuous straight segment. Use imaging especially when (1) the pressure taken more than the rated burst pressure, (2) an OPN balloon size is >= 3 mm (3) using 1:1 size OPN balloon in a tortuous segment.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [31] Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention
    Li, Jianan
    Qiu, Hong
    Yan, Lirong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Tang, Yida
    Xu, Bo
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (11) : 1739 - 1745
  • [32] Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation
    Xu Zhang
    Yangxun Wu
    Chao Lv
    Shizhao Zhang
    Haiping Liu
    Yuyan Wang
    Yuting Zou
    Liu’an Qin
    Junmeng Zhang
    Tong Yin
    Thrombosis Journal, 20
  • [33] Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
    Ullah, Waqas
    Gowda, Smitha Narayana
    Fischman, David
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 23 : 1 - 6
  • [34] Efficacy and safety of vorapaxar for the prevention of adverse cardiac events in patients with coronary artery disease: a metaanalysis
    Tan, Guangyi
    Chen, Jian
    Liu, Mao
    Yeh, James
    Tang, Wenyi
    Ke, Jianting
    Wu, Wei
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2016, 6 (02) : 101 - 108
  • [35] Safety of bariatric surgery in patients with coronary artery disease
    Ruzieh, Mohammed
    Rogers, Ann M.
    Banerjee, Kalins
    Soleymani, Taraneh
    Zhan, Xiang
    Foy, Andrew J.
    Peterson, Brandon R.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (12) : 2031 - 2037
  • [36] Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation
    Zhang, Xu
    Wu, Yangxun
    Lv, Chao
    Zhang, Shizhao
    Liu, Haiping
    Wang, Yuyan
    Zou, Yuting
    Qin, Liu'an
    Zhang, Junmeng
    Yin, Tong
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [37] Lesion Preparation With Scoring Balloon Improves the Efficacy of Drug-Coated Balloon Treatment in Patients With De Novo Coronary Artery Disease
    Ge, Zhen
    Chen, Shao-Liang
    Zhang, Junjie
    Gao, Xiaofei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B136 - B136
  • [38] Efficacy and pharmacokinetics of gallopamil in patients with coronary artery disease
    Ferrara, N
    Longobardi, G
    Guerra, N
    Nicolino, A
    Acanfora, D
    Furgi, G
    Odierna, L
    Rosiello, R
    Rengo, F
    PHARMACOLOGICAL RESEARCH, 1996, 34 (1-2) : 37 - 41
  • [39] Fetuin-A is associated with calcified coronary artery disease
    Mori, Katsuhito
    Ikari, Yuji
    Jono, Shuichi
    Emoto, Masanori
    Shioi, Atsushi
    Koyama, Hidenori
    Shoji, Tetsuo
    Ishimura, Eiji
    Inaba, Masaaki
    Hara, Kazuhiro
    Nishizawa, Yoshiki
    CORONARY ARTERY DISEASE, 2010, 21 (05) : 281 - 285
  • [40] Contemporary Interventional Approach to Calcified Coronary Artery Disease
    Sung, Jonathan Gabriel
    Lo, Sidney T. H.
    Lam, Ho
    KOREAN CIRCULATION JOURNAL, 2023, 53 (02) : 55 - 68